US Patent

US11191908 — Syringe shock absorber for use in an injection device

Formulation · Assigned to Antares Pharma Inc · Expires 2035-10-18 · 9y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a shock-absorbing sleeve for use in injection devices, such as auto-injectors, to distribute force on medicament chambers.

USPTO Abstract

An injection device, for example, an auto-injector of any type, includes a sleeve configured to hold a medicament chamber. The sleeve may be sufficiently deformable such that it functions as a shock absorbing member to distribute the force exerted on the medicament chamber during use of the injection device.

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: US11191908
Jurisdiction: US
Classification: Formulation
Expires: 2035-10-18
Drug substance claim: No
Drug product claim: Yes
Assignee: Antares Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.